<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38648">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02603289</url>
  </required_header>
  <id_info>
    <org_study_id>CSP-300313-00</org_study_id>
    <nct_id>NCT02603289</nct_id>
  </id_info>
  <brief_title>One Week Aligner Evaluation</brief_title>
  <official_title>One Week Aligner Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Align Technology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Align Technology, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate that changing aligners weekly provides similar
      results to changing aligners every two weeks.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Planned to Final Tooth Position</measure>
    <time_frame>Through study completion, an average of 2 years</time_frame>
    <description>Test vs Historical Control Group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment time</measure>
    <time_frame>Through study completion, an average of 2 years</time_frame>
    <description>Length of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Quality of Life</measure>
    <time_frame>Through study completion, an average of 2 years</time_frame>
    <description>Assessment of QoL</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">287</enrollment>
  <condition>Malocclusion</condition>
  <arm_group>
    <arm_group_label>Teen</arm_group_label>
    <description>&lt; 17 years of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult</arm_group_label>
    <description>17 years of age or older</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult with Primer Aligners</arm_group_label>
    <description>17 years of age or older This group will get Primer Aligners</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Invisalign</intervention_name>
    <arm_group_label>Teen</arm_group_label>
    <arm_group_label>Adult</arm_group_label>
    <arm_group_label>Adult with Primer Aligners</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Invisalign patients from selected pool of investigators
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must have fully erupted dentition except for 2nd and 3rd molars

          -  For Teen treatment group, subjects ages &lt;17 years of age

          -  For Adult treatment group, subjects â‰¥17 years of age

        Exclusion Criteria:

          -  Subject has undergone any accelerated orthodontic treatment prior to or during
             treatment as part of this study

          -  Subject with active caries

          -  Subject with periodontal disease

          -  Subject with TMD symptoms

          -  Subject has known allergy to latex or plastic

          -  Subjects who are pregnant or will become pregnant during treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Align Technology, Inc.</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 30, 2017</lastchanged_date>
  <firstreceived_date>November 10, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Malocclusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
